RAP 0.00% 20.5¢ resapp health limited

Ann: First patients recruited in COVID-19 clinical study in India, page-87

  1. 6,707 Posts.
    lightbulb Created with Sketch. 850
    Yeo agree...time to consolidate and get some more companies on board and using ResAppDx and also Sleepcheck as a bonus why not test for this too type of promo. Due for an update I would say soon re the India testing regiment and progress. Don't reckon they will forward pass any detail but maybe throw in the usual line that says results are "encouraging" so far. There is quite a distance to travel with this one but hey India is India and RAP are using a clinical trial company to operate the gig over there so fingers (and toes) crossed...next 6 or 7 days should see some news anyway...hold tight!
    Next month or two should see some more signings and some revenue news...hopefully Medgate will have the ball rolling and some more encouraging comments on the future use of RAP tech.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.